Nippon India Pharma Fund Leads 20-Year Returns; SIP Data

MUTUAL-FUNDS
Whalesbook Logo
AuthorAarav Shah|Published at:
Nippon India Pharma Fund Leads 20-Year Returns; SIP Data

A 20-year analysis shows Nippon India Pharma Fund delivered 19.51% annualised returns, turning a ₹10,000 monthly SIP into ₹1.96 crore. While these results highlight long-term wealth creation, investors should note that sectoral and mid-cap funds carry inherent volatility risks that may not suit every profile.

What Happened

A recent analysis of 1,209 equity mutual funds has highlighted the performance of long-standing schemes that have completed two decades in the market. Among these, three funds managed by Nippon India Mutual Fund emerged as top performers in terms of annualised returns. The Nippon India Pharma Fund led the group with a 19.51% annualised return over the 20-year period, demonstrating how consistent investment through a Systematic Investment Plan (SIP) can accumulate significant wealth over time. The study covered funds that have weathered multiple market cycles since their inception in the early 2000s.

Top Performers and Investment Metrics

The analysis revealed that sectoral and mid-cap categories were primary drivers of long-term growth. The Nippon India Pharma Fund, which focuses on the healthcare sector, has maintained a strong track record since June 2004. Similarly, the Nippon India Banking & Financial Services Fund and the Nippon India Growth Mid Cap Fund secured top rankings, showing competitive risk-adjusted returns. For instance, the Banking & Financial Services Fund reported an alpha of 3.37, indicating its ability to outperform its benchmark index, while the Growth Mid Cap Fund has consistently outperformed the BSE 150 MidCap TRI since its inception in 1995.

Why Sectoral Funds Require Caution

While the 20-year return figures are attractive, investors should understand the nature of the funds involved. Sectoral funds like the pharma and banking schemes are concentrated in specific industries. This concentration means they are heavily exposed to sector-specific risks, such as regulatory changes, shifts in government healthcare policies, or interest rate cycles affecting banking. Unlike diversified equity funds, these schemes lack the buffer of other sectors when their primary industry faces a downturn. Consequently, these funds often exhibit higher volatility, which can lead to significant swings in portfolio value during market corrections.

The Mid-Cap Risk Factor

Mid-cap funds are another category that contributed to these strong long-term results. However, mid-cap companies typically have smaller market capitalisations and can be more sensitive to economic slowdowns than large-cap peers. During periods of market stress, these stocks often see deeper price drops. Investors should evaluate whether their personal risk tolerance can handle the increased fluctuations associated with mid-cap and sectoral investments before allocating significant capital to such themes.

What Investors Should Track

When looking at long-term fund performance, historical returns are only one part of the picture. Investors should review the fund's current portfolio quality, the experience of the fund management team, and the consistency of the strategy over different market phases. It is also essential to check the expense ratio, as higher costs can eat into returns over two decades. Before investing, assess your own financial goals and ensure that these concentrated or mid-cap funds align with your overall asset allocation strategy rather than relying solely on past performance data.

Disclaimer:This article is published for informational purposes only. While reasonable efforts are made to ensure accuracy, completeness, and timeliness, readers are encouraged to independently verify information before making any decisions based on the content. The views and information presented are subject to editorial review and may be updated without notice.